Self-Assembling Depsipeptide Dendrimers and Dendritic Fullerenes
CH2Cl2/EtOAc, 9:1). Yield: 175.00 mg (83%); pink powder. 1H
NMR (400 MHz, CDCl3/[D5]pyridine, 25 °C): δ = 0.38 (s, 18 H,
SiCH3), 1.64 (s, 18 H, CH3), 2.71 (s, 12 H, OCH3), 3.88 (s, 8 H,
[M]+. C124H128N16O12Zn·2CH2Cl2 (2213.59): calcd. C 66.20, H
5.65, Cl 6.41, N 10.12, O 8.67, Zn 2.95; found C 66.74, H 5.87, N
10.04. UV/Vis (CH2Cl2): λ (ε) = 303 (103400), 424 (432700), 552
3
CH2), 7.84 (m, 8 H, Bn), 8.17 (d, JH,H = 8.0 Hz, 4 H, Bn), 8.66
(22800), 591 (5700 Lmol–1 cm–1) nm. IR (ATR): νmax = 2970, 2360,
˜
3
3
(d, JH,H = 4.8 Hz, 4 H, pyrrole), 8.76 (d, JH,H = 4.8 Hz, 4 H,
pyrrole) ppm. 13C NMR (100.5 MHz, CDCl3/[D5]pyridine, 25 °C):
δ = 0.50 (SiCH3), 32.16 (CH3), 35.59 (CCH3), 58.33 (OCH3), 73.52
(CH2), 95.58, 105.68 (CϵC), 115.90, 119.81, 122.29, 122.49, 130.41
(Bn), 130.41, 131.32 (8 C, pyrrole), 132.28, 134.97, 136.83, 139.71,
144.07 (Bn), 150.16, 150.23 (pyrrole), 151.77 (Bn) ppm.
C70H76N4O4Si2Zn·0.5H2O (1167.95): calcd. C 71.30, H 6.26, N
5.04, O 6.48, Zn 5.88; found C 71.60, H 6.55, N 5.32. MS (FAB):
m/z = 1158 [M+]. UV/Vis (CH2Cl2): λ (ε) = 423 (482500), 551
2342, 1738, 1586, 1523, 1447, 1366, 1299, 1230, 1217, 1205, 1154,
1118, 996, 889, 797, 720 cm–1.
Synthesis of Compound 16: Nickel(II) acetylacetonate (29.31 mg,
114.10 µmol) was added to a solution of porphyrin 12 (25.00 mg,
22.82 µmol) in toluene (20.0 mL), and the reaction mixture was
heated at reflux for 12 h. The solution was concentrated to dryness
and purified by column chromatography [SiO2; CH2Cl2/hexane
(8:2); Rf = 0.46]. Yield: 21.0 mg (80%); cherry-red powder. 1H
NMR (400 MHz, CDCl3, 25 °C): δ = 0.37 (s, 18 H, CH3), 1.61 (s,
18 H, CH3), 2.86 (s, 12 H, CH3), 3.90 (s, 8 H, CH2), 7.83 (m, 8 H,
(21800), 589 (3200 Lmol–1 cm–1) nm. IR (ATR): νmax = 2970, 2360,
˜
2157, 1738, 1460, 1365, 1248, 1228, 1217, 1203, 1115, 996, 967,
3
3
Bn), 8.02 (d, JH,H = 8.4 Hz, 4 H, Bn), 8.61 (d, JH,H = 5.2 Hz, 4
H, pyrrole), 8.70 (d, 3JH,H = 5.2 Hz, 4 H, pyrrole) ppm. 13C NMR
(100.5 MHz, CDCl3, 25 °C): δ = 0.46, 32.09 (CH3), 35.60 (CCH3),
58.58 (CH3), 73.29 (CH2), 96.00, 105.30 (CϵC), 115.07, 118.72,
122.93, 123.12, 130.95 (Bn), 132.14, 123.69 (pyrrole), 134.03,
134.30, 139.53, 141.54, 143.16, 143.17, 152.40 (pyrrole, Bn) ppm.
MALDI TOF/MS: m/z = 1150 [M]+. C70H76N4NiO4Si2·1.5CH2Cl2
(1276.41): calcd. C 67.11, H 6.22, Cl 8.31, N 4.38, Ni 4.59, O 5.00,
Si 4.39; found C 66.69, H 6.19, N 4.15. UV/Vis (CH2Cl2): λ (ε) =
858, 843, 797, 758, 721 cm–1.
Synthesis of Compound 14: A solution of TBAF in THF (1 ,
0.86 mL) was added dropwise to a solution of 13 in anhydrous
THF (10 mL). The reaction mixture was stirred under inert condi-
tions at room temp. for 12 h. The solution was concentrated to
dryness, and the residue was dissolved in CH2Cl2 (30 mL) and ex-
tracted with aq. NaHCO3 (5%, 2ϫ30 mL). The organic layer was
separated, washed with water (2ϫ30 mL) and dried with Na2SO4.
The solution was filtered, concentrated to dryness and purified by
column chromatography [SiO2; CH2Cl2/EtOAc (97:3); Rf = 0.52].
Yield: 115.00 mg (79%); pink powder. 1H NMR (400 MHz, CDCl3/
[D5]pyridine, 25 °C): δ = 1.63 (s, 18 H, CH3), 2.71 (s, 12 H, OCH3),
3.33 (s, 2 H, CϵH), 3.88 (s, 8 H, CH2), 7.84 (m, 8 H, Bn), 8.17 (d,
417 (264200), 528 (20900 Lmol–1 cm–1) nm. IR (ATR): νmax = 2961,
˜
2924, 2822, 2159, 1605, 1499, 1393, 1351, 1290, 1250, 1220, 1194,
1102, 1003, 952, 930, 863, 843, 815, 803, 761, 716 cm–1.
Synthesis of Compound 19: (4-Iodophenyl)isocyanuric acid (17;
150.00 mg, 0.45 mmol), Pd(PPh3)2Cl2 (3.00 mg, 5.00 µmol) and
CuI (3.00 mg, 15.00 µmol) were dissolved in THF (10 mL). To this
solution, NEt3 (4 mL) and 4-ethynylbenzaldehyde (18; 70.00 mg,
0.54 mmol) were added, and the reaction mixture was stirred at
room temp. for 16 h. The precipitate was filtered off, the solvent
was evaporated, and the crude product was purified by column
chromatography [SiO2; CH2Cl2 Ǟ CH2Cl2/THF (1:1)]. Yield:
3
3JH,H = 8.0 Hz, 4 H, Bn), 8.67 (d, JH,H = 4.4 Hz, 4 H, pyrrole),
8.77 (d, 3JH,H = 4.4 Hz, 4 H, pyrrole) ppm. 13C NMR (100.5 MHz,
CDCl3/[D5]pyridine, 25 °C): δ = 32.16 (CH3), 35.59 (CCH3), 58.31
(OCH3), 73.52 (CH2), 78.47 (CϵC), 84.30 (CϵCH), 115.96,
119.69, 121.37, 122.52, 130.56 (Bn), 131.37, 132.30 (pyrrole),
135.01, 136.10, 136.84, 139.72, 144.36 (Bn), 150.13, 150.27
(pyrrole), 151.80 (Bn) ppm. MS (FAB): m/z
=
1012 [M]+.
1
110.00 mg (73%). H NMR (400 MHz, [D8]THF, 25 °C): δ = 7.17
C64H60N4O4Zn·0.5H2O (1023.59): calcd. C 74.49, H 5.52, N 5.79,
O 7.44, Zn 6.76; found C 74.08, H 5.88, N 5.16. UV/Vis (CH2Cl2):
λ (ε) = 423 (636200), 551 (20000), 588 (16600 Lmol–1 cm–1) nm. IR
3
3
(d, JH,H = 7.02 Hz, 2 H, Bn), 7.45 (d, JH,H = 8.5 Hz, 2 H, Bn),
3
3
7.80 (d, JH,H = 8.7 Hz, 2 H, Bn), 7.98 (d, JH,H = 6.7 Hz, 2 H,
Bn), 10.93 (s, 1 H, HC=O), 11.59 (br., 2 H, NH) ppm. 13C NMR
(100.5 MHz, [D8]THF, 25 °C): δ = 87.54, 90.56 (CϵC), 120.16,
126.26, 130.14, 130.38, 130.51, 133.43, 134.03, 136.06, 147.95,
(ATR): ν
= 3003, 2970, 2360, 2341, 1738, 1456, 1365, 1229,
˜
max
1217, 1205, 1102, 1065, 998, 908, 809, 797, 720 cm–1.
Synthesis of Compound 15: Compound 3 (87.20 mg, 130.04 µmol)
was dissolved in anhydrous THF/NEt3 (2:1, 17.5 mL). Pd2(dba)3
(114.20 mg, 124.71 µmol), AsPh3 (191.40 mg, 625.02 µmol) and 14
(55.00 mg, 542.10 µmol) were added to this solution, and the reac-
tion was allowed to proceed in the dark under inert conditions
for 6 d. The solution was concentrated to dryness and purified by
repeated column chromatography [SiO2; CH2Cl2 Ǟ CH2Cl2/
147.99 (Bn), 192.78 (HC=O) ppm. IR (ATR): ν
= 3406, 2361,
˜
max
1765, 1714, 1294, 1177, 1152, 1025, 1004, 821, 763, 733 cm–1.
Synthesis of Compound 20: Compound 19 (50.00 mg, 0.15 mmol)
was dissolved in THF (10 mL) before a solution of C60 (152.00 mg,
0.22 mmol) in toluene (300 mL) was added. After stirring under
the exclusion of light for 30 min, sarcosine (18.00 mg, 0.22 mmol)
MeOH (99:1) Ǟ CH2Cl2/MeOH (98:2) Ǟ CH2Cl2/MeOH (98:5)]. was added, and the reaction mixture was heated at 110 °C under
The dark-red substance was dissolved in CH2Cl2 and precipitated
the exclusion of air and light for 22 h. The monoadduct was sepa-
rated from C60 and higher adducts by column chromatography
with n-pentane. Yield: 35.00 mg (31%); violet powder. 1H NMR
(400 MHz, [D8]THF, 25 °C): δ = 1.10 (s, 36 H, CH3), 1.65 (s, 18 [SiO2; toluene Ǟ toluene/EtOAc (1:1)]. The resulting brown solid
H, CH3), 2.29 (s, 8 H, CH2), 2.78 (s, 12 H, OCH3), 3.95 (s, 8 H, was dissolved in CS2 and precipitated with n-pentane to remove
3
CH2), 7.77 (t, JH,H = 8.0 Hz, 4 H, Py), 7.94 (s, 4 H, Bn), 8.06
solvent residues. Yield: 46 mg (29%). 1H NMR (400 MHz, CS2/
3
(overl. d, 20 H, Bn, Py), 8.29 (d, JH,H = 7.9 Hz, 4 H, Bn), 8.45 (s,
4 H, Bn), 8.57 (s, 2 H, Bn), 8.69 (d, JH,H = 4.5 Hz, 4 H, pyrrole),
[D8]THF, 25 °C): δ = 4.77 (d, 2JH,H = 9.5 Hz, 1 H, NCH2), 2.94 (s,
3
2
3 H, CH3), 4.97 (s, 1 H, NCH), 4.98 (d, JH,H = 9.5 Hz, 1 H,
3
3
8.84 (d, JH,H = 4.5 Hz, 4 H, pyrrole), 9.09 (br., 4 H, NH), 9.79
NCH2), 7.12 (d, 3JH,H = 8.6 Hz, 2 H, Bn), 7.46 (d, JH,H = 8.8 Hz,
(br., 2 H, NH) ppm. 13C NMR (100.5 MHz, [D8]THF, 25 °C): δ =
2 H, Bn), 7.54 (d, JH,H = 8.55 Hz, 2 H, Bn), 7.77 (d, JH,H =
3
3
30.00 (CH3), 31.63 (CCH3), 31.97 (CH3), 35.70 (CCH3), 50.71 6.7 Hz, 2 H, Bn), 10.51 (s, 2 H, NH) ppm. 13C NMR (100.5 MHz,
(CH2), 57.94 (OCH3), 73.84 (CH2), 89.51, 91.97 (CϵC), 110.20, CS2/[D8]THF, 25 °C): δ = 62.01 (CH3), 69.10, 70.40 (sp3C C60),
110.41 (Py), 116.52, 120.28, 122.54, 122.73, 124.95, 127.54, 130.44
(Bn), 131.39, 132.39 (pyrrole), 134.27, 135.68, 136.80 (Bn), 140.57
(Py), 145.03, 150.58, 150.67, 151.25 (Bn, Py), 151.66, 151.78 (pyr-
role), 164.88, 170.77 (C=O) ppm. MALDI TOF/MS: m/z = 2736
78.16 (NCH), 90.12, 90.57 (CϵC), 123.50, 123.67, 129.08, 129.37,
131.80, 133.72, 135.66, 136.02, 136.47, 136.64 (Bn), 140.07, 140.28,
140.35, 141.34, 141.66, 141.75, 141.97, 142.17, 142.28, 142.69,
142.75, 143.13, 143.26, 144.45, 144.70, 144.73, 144.77, 144.84,
Eur. J. Org. Chem. 2010, 5010–5029
© 2010 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim
www.eurjoc.org
5027